Resistance to Targeted Therapies in Multiple Myeloma
English | 2021 | ISBN: 3030734390 | 171 Pages | PDF EPUB | 3 MB
Multiple Myeloma remains an incurable malignancy. As the disease progresses, it invariably becomes resistant to treatment and almost all patients develop refractory disease. There are multiple different types of targeted therapies and many of them are used in combination at different stages of disease. Targeted therapies that are approved to be used include Proteasome Inhibitors, Immunomodulatory Drugs and Monoclonal Antibodies. Second and third generations of these drugs are developed to overcome resistance and they have unique mechanism of actions. Targeted therapies that are undergoing clinical trials include CAR-T cells, bi-specific antibodies, vaccines, ubiquitin ligase inhibitors and BCL-2 inhibitors.
Buy Premium From My Links To Get Resumable Support,Max Speed & Support Me
https://uploadgig.com/file/download/d715323E4D057337/e4kwk.Resistance.to.Targeted.Therapies.in.Multiple.Myeloma.rar
https://rapidgator.net/file/5658f610840193965785d31510c149da/e4kwk.Resistance.to.Targeted.Therapies.in.Multiple.Myeloma.rar.html
http://nitro.download/view/C474C7D5D26215E/e4kwk.Resistance.to.Targeted.Therapies.in.Multiple.Myeloma.rar